Rasayana Therapy

There is mental and physical trauma associated with post operative situation of the patient. And before they can fully recover from the trauma, patients need to embark on the post surgery chemotherapy cycles. In this condition it is used as a preventive measure to avoid recurrence of the disease or also called Prophylactic Treatment. In spite of the need and current practice, studies show that such therapies can be the cause of second cancer or it can trigger growth of the existing cancer. Considering this risk, Rasayana may play an important role in strengthening the body in order to help delay recurrence and help increase disease-free survival.

Rasayan therapy, also helps to recover fast from the weakness induced by surgery.

Micrometastasis – there are times when the PET scan or CT scan do not show any presence of growth or recurrence. The growth is such that it can be identified or seen only when they exhibit secondaries and visible with available imaging techniques. Till then it remains unidentified. This process is likely to be undergoing at any stage/treatment of disease.

Rasayana therapy helps to address such issues of recurrence post treatments/surgery and micro metastasis.

Often cancer patients are found to have tolerability issues with chemotherapy / other conventional therapies. It means that such therapies itself becomes a cause to many complications specially due to fragility of cancer patients or other comorbid conditions that add substantial risk to the situation. In such cases, it often refrains patients from further conventional treatment. Such cases may respond well to Rasayana treatment and may eventually become eligible for conventional therapies if any.

Some cases cannot be operated when they have locally advanced tumor with or without metastasis. Some times major blood vessels are involved, which become a potential risk. Acute inflammation also does not permit surgical interference. In such situations, Rasayana therapy helps improve the quality of life and physical performance status of the patient. The immunomodulatory action and apoptosis inducer or TGD – Tumor growth delay is observed by Rasayana Therapy in patient-reported outcomes.

Recent studies have shown that Chemotherapy has limited benefit for cancer patients and hence newer therapies are being innovated. Sometimes patients show adverse drug reactions which is difficult to manage and the overall quality of health is compromised. It is reported that nearly 27% of people have found to have adverse drug reactions after chemotherapy. Cancer cells being clever in nature, mutate themselves leading to resistance.

Patients who are under Life-threatening grade IV conditions cannot be administered chemotherapy. It is also seen that in spite of multiple cycles of chemotherapy, there is no tumor regression. There is frequent hospitalization due to adverse effects and the quality of life is severely affected. This entire management leads to affect tumor biology adversely and the resistant tumors are formed. Rasayana therapy due to its immunomodulation approach taken along with chemotherapy may play a synergistic role in tumor regression and overall improvement of quality of life.

A major obstacle for the treatment by hormonal therapy is the resistance to treatment. Hormone therapy has been found to have limitations. It cannot be stopped since it can cause a relapse of the symptoms. When a patient shows progression while being on hormonal therapy then generally it is considered as a resistant case. Further to this, Rasayana Therapy may be an alternative to such patients.

Immunotherapy is an emerging therapy used to enhance the immune system in order to fight cancer causing factors. It has yielded results between 15% – 25% in varied range. This therapy is highly costly and its duration is uncertain.

Rasayan therapy may be an alternative for refractory or unaffordable patients.

High dose of radiation is used to destroy cancer cells and shrink tumors. It slows down the growth of cancer cells. The DNA structure of the cells is irreparably damaged that arrests its further growth. It is a slow process and takes time during which the body has to go through side effects such as extreme dryness, pigmentation and destruction of moisturising mechanism etc.

Rasayan therapy is taken together with radiotherapy showing encouraging results to improve quality of life of patients.

Targeted chemotherapy aims at specific genes and proteins of the cancer cells. Their destruction stops cancer growth. However, when patients become resistant to targetted chemotherapy Rasayana therapy may help in increasing overall survival along with quality of life of the patients. Rasayana Therapy can be a good option for unaffordable patients.

When the end arrives, humans need to die with the same dignity they have led their life. A good life and an equally fine exit is possible with Rasayan therapy with minimal sufferings – an ideally suited therapy at hospices and centres for the terminally ill. The overall survival extension is made possible with Rasayana Therapy with high health quality.

There is no treatment dedicated for geriatric cancers. Majority of clinical trials are being done on patients below age of 65 yrs. Many a times cancer is prevalent in age group exceeding 65 yrs. At this age it is likely that patients are suffering from one or more comorbidities life hypertension, diabetes, heart disease etc. Old age along with comorbid conditions makes it extremely challenging to select the therapy which will offer better risk benefit ratio. On the other side patients and relatives apparently expect better quality and good overall survival. To meet such goals Rasayana Therapy can be a potential alternative to such Geriatric patients.

The health parameters are a challenge as the cancer growth occurs. Rasayan therapy works wonderfully well for such patients where care is taken to protect their other health parameters. Leading to better quality of life with better survival.

Modern medicine has got tremendous success in paediatric cancer due to its curative intent. Barring these cancers there are certain class of paediatric cancers which do not respond to available therapies. Rasayana Therapy can be a potential option to such patients to meet respective objectives. Sometimes Rasayana Therapy can be an option post resection of tumors in paediatric cancers. As per real world evidence Rasayana is found to be safe for Paediatrc patients also.

These patients are similar to the geriatrics where the health parameters are fragile. Rasayan therapy helps strike the right balance between maintaining the health parameters as well as destroying the tendency of the cancer cells to grow leading to good overall survival.

These are rare occurrences where cancer is diagnosed during the pregnancy or still rarer that a woman would like to conceive after cancer diagnosis. Rasayan therapy helps maintain the foetal growth as well as potential to control the cancer growth leading to successful delivery of a child and making a mother eligible for other therapies. This is highly subjective area.

Organ failure such liver failure, kidney failure etc. can be the result of the cancer therapies or co-morbidities. Rasayana Therapy helps maintain organ functionining and also addresses the inherent cancer that is at the root of the patients health if duly indicated for.